WARNINGS
Capitrol should not be used on acutely inflamed (exudative) lesions of the scalp.
PRECAUTIONS
Information for Patients
Exercise care to prevent Capitrol from entering the eyes. If contact occurs, the patient should flush eyes with cool water. Discoloration of light-colored hair (e.g. blond, gray or bleached) may follow use of this preparation.
Irritation and a burning sensation on the scalp and adjacent areas have been reported.
Drug/Laboratory Test Interactions
There is no known interference of Capitrol with laboratory tests.
Carcinogenesis, Mutagenesis
No long term studies in animals have been performed to evaluate the carcinogenic potential of Capitrol.
Results of the in vitro Ames Salmonella/Microsome Plate test show that Capitrol does not demonstrate genetic activity and is considered non-mutagenic.
Pregnancy Category C
Animal reproduction studies have not been conducted with Capitrol. It is also not known whether Capitrol can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Capitrol should be given to a pregnant woman only if clearly needed.
Nursing Mothers
It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Capitrol is administered to a nursing woman.
Pediatric Use
Specific studies to demonstrate the safety and effectiveness for use of Capitrol in children have not been conducted.
|
